undamentalytics Newsletter
Sign in

Revvity cash flow statement

In fiscal 2025, Revvity's operations generated $583m of cash; it spent $73.5m on capital projects, leaving free cash flow of $509m. It returned $32.8m in dividends and $821m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Jan 20102010Jan 20112011Jan 20122012Dec 20122013Dec 20132014Dec 20142015Jan 20162016Jan 20172017Dec 20172018Dec 20182019Dec 20192020Jan 20212021Jan 20222022Jan 20232023Dec 20232024Dec 20242025Dec 2025LTMJul 2026
Cash from operations1491642251521592822873512883113638921,41168091628583628
Depreciation and amortisation8189111125127110105100105181214202311427432428405243
Stock-based pay141215211414171725293227305241382310
Capital spending263431423927283239937664868681877470
Free cash flow1231311941101202542593192492182878291,32559410542509558
Free cash flow after stock pay109118179891062402423022241892568021,295543−32504487548
Dividends paid333332323232323131313131323535343332
Share buybacks157311021276676152457677381389370821476

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: PODD vs RVTYGMED vs RVTYQDEL vs RVTY

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Revvity's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Revvity.